Ashley Zehnder
Co-founder and CEO at Fauna Bio
Veterinarian-scientist, Co-founder and CEO at Fauna Bio.
Ashley’s research focused on translational science and veterinary informatics at Stanford, earning a PhD in Cancer Biology and her work spans >20 peer-reviewed publications, including Cell, Nature and Nature Medicine and several book chapters. She is a boarded avian veterinarian with specialty training in exotic/non-traditional species. She is a co-founder of the Exotic Species Cancer Research Alliance and incoming president of the Association of Avian Veterinarians.
Visit website: https://www.faunabio.com/blog/founder-story-ashley-zehnder
See also: 
Fauna Bio
- Developing human therapeutics from animal genomics
Details last updated 06-Sep-2021
Ashley Zehnder News
Fauna Bio hunts for novel obesity drugs in $494m Lilly partnership
Longevity Technology - 21-Dec-2023
Fauna's AI platform explores animal data to unlock breakthroughs in weight management
Read more...Lifespan.io summarises the proceedings of the Buck Institute's Longevity Summit
Lifespan.io (LEAF) - 20-Jan-2023
Another reminder of the amount of research, with multiple approaches, about to go into clinical trials
Read more...Fauna Bio finds new avenues for drug discovery through animal genomics
Longevity Technology - 27-Aug-2021
By investigating self-healing mechanisms in animals, Fauna bio aims to cure human diseases.
Read more...
